{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:40:22Z","timestamp":1772815222769,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.vaccine.2007.03.039","type":"journal-article","created":{"date-parts":[[2007,4,12]],"date-time":"2007-04-12T11:12:59Z","timestamp":1176376379000},"page":"4595-4601","source":"Crossref","is-referenced-by-count":31,"title":["Oral administration of BCG encapsulated in alginate microspheres induces strong Th1 response in BALB\/c mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Soheila","family":"Ajdary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faramarz","family":"Dobakhti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Taghikhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Riazi-Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahnaz","family":"Rafiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Rafiee-Tehrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.03.039_bib1","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0140-6736(90)91074-K","article-title":"Modern vaccines. Mycobacterial diseases","volume":"335","author":"Fine","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.03.039_bib2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.03.039_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of Bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyzes of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2007.03.039_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","article-title":"Needle-free vaccine delivery","volume":"58","author":"Giudice","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2007.03.039_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2249.2001.01667.x","article-title":"Intranasal BCG vaccination protects BALB\/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs","volume":"126","author":"Lyadova","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.03.039_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.039_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT-versus Peyer's-patch mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2007.03.039_bib8","first-page":"107","article-title":"BCG complications: estimates of the risk among vaccinated subjects and statistical analysis of their main characteristics","volume":"21","author":"Lotte","year":"1984","journal-title":"Adv Tuberc Res"},{"key":"10.1016\/j.vaccine.2007.03.039_bib9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0264-410X(99)00386-2","article-title":"Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intra-gastric administration in mice","volume":"18","author":"Lagranderie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.039_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0168-3659(90)90133-E","article-title":"Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches","volume":"11","author":"Eldridge","year":"1990","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2007.03.039_bib11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0264-410X(91)90295-H","article-title":"Controlled release microparticles for vaccine development","volume":"9","author":"O\u2019Hagan","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.039_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1711.2005.01369.x","article-title":"Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: anatomical sites of bacterial replication and immune activity","volume":"83","author":"Aldwell","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2007.03.039_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/IAI.71.1.101-108.2003","article-title":"Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice","volume":"71","author":"Aldwell","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.039_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0144-8617(88)90001-X","article-title":"Alginates","volume":"8","author":"Gacesa","year":"1988","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.vaccine.2007.03.039_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0168-3659(95)00155-7","article-title":"Oral vaccination with alginate microsphere systems","volume":"39","author":"Bowersock","year":"1996","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2007.03.039_bib16","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/S0264-410X(98)00437-X","article-title":"Oral vaccination of animals with antigens encapsulated in alginate microspheres","volume":"17","author":"Bowersock","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.039_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-1759(01)00429-X","article-title":"Multiple intestinal loops provide an in vivo model to analyze multiple mucosal immune response","volume":"256","author":"Gerdts","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2007.03.039_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0264-410X(00)00170-5","article-title":"Immunization with DNA, adenovirus or both in biodegradable alginate analysis of the microspheres: effect of route of inoculation on immune response","volume":"19","author":"Mittal","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.039_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(02)00280-8","article-title":"Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres","volume":"85","author":"Kim","year":"2002","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2007.03.039_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1080\/02652040601034013","article-title":"Stabilizing effects of calcium alginate microspheres on Mycobacterium bovis BCG intended for oral immunization","volume":"23","author":"Dobakhti","year":"2006","journal-title":"J Microencapsul"},{"key":"10.1016\/j.vaccine.2007.03.039_bib21","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1086\/313864","article-title":"Mucosal Bacille Calmette-Guerin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific IFN-\u03b3 responses","volume":"30","author":"Hoft","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.03.039_bib22","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1128\/IAI.68.10.5657-5662.2000","article-title":"Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes","volume":"68","author":"Abolhassani","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.039_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2006.01.002","article-title":"Mucosal delivery of vaccine antigens and its advantages in pediatrics","volume":"58","author":"De Magistris MT","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2007.03.039_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0165-2478(97)00131-4","article-title":"Induction of pulmonary immunity in cattle by oral administration of ovalbumin in alginate microspheres","volume":"60","author":"Bowersock","year":"1998","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2007.03.039_bib25","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for IFN-gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.03.039_bib26","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/infdis\/167.6.1481","article-title":"T cell response to Mycobacterium tuberculosis","volume":"167","author":"Orme","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.03.039_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0171-2985(11)80459-6","article-title":"Experimental approaches to mechanisms of protection and pathogenesis in M. tuberculosis infection","volume":"191","author":"Bloom","year":"1994","journal-title":"Immunobiol"},{"key":"10.1016\/j.vaccine.2007.03.039_bib28","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.4049\/jimmunol.154.7.3359","article-title":"Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice","volume":"154","author":"Andersen","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.03.039_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.64.1.1-9.1996","article-title":"Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine straines","volume":"64","author":"Lagranderie","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.039_bib30","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1128\/IAI.68.12.6946-6953.2000","article-title":"Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL\/6 and BALB\/c mice","volume":"68","author":"Wakeham","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.039_bib31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jac\/dkg165","article-title":"Alginate-based oral delivery system for tuberculosis: pharmacokinetics and therapeutic effects","volume":"51","author":"Qurrat-ul-ain","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2007.03.039_bib32","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.biomaterials.2004.06.011","article-title":"Physically crosslinked alginate\/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs","volume":"26","author":"Lin","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2007.03.039_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/026520499289022","article-title":"Calcium alginate microparticles for oral administration. I: effect of sodium alginate type on drug release and drug entrapment efficiency","volume":"16","author":"Takka","year":"1999","journal-title":"J Microencapsul"},{"key":"10.1016\/j.vaccine.2007.03.039_bib34","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1086\/313878","article-title":"Comparison of the protective efficacy of Bacille Calmette-Guerin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis","volume":"30","author":"Williams","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.03.039_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/S0100-879X2001000100010","article-title":"A single strain of Mycobacterium bovis bacillus Calmette-Guerin (BCG) grown in two different media evokes distinct humoral immune responses in mice","volume":"34","author":"Petricevich","year":"2001","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2007.03.039_bib36","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.4049\/jimmunol.155.4.2057","article-title":"Dissection of strain difference in aquired protective immunity against Mycobacterium bovis Calmette-Guerin Bacillus","volume":"155","author":"Yoshida","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.03.039_bib37","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1128\/IAI.73.3.1903-1905.2005","article-title":"Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis","volume":"73","author":"Aldwell","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.039_bib38","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/j.vaccine.2005.01.150","article-title":"Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis","volume":"23","author":"Buddle","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.039_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0264-410X(03)00539-5","article-title":"Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums","volume":"22","author":"Aldwell","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.039_bib40","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.vaccine.2005.11.017","article-title":"Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis","volume":"24","author":"Aldwell","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.039_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(97)00054-0","article-title":"Bioadhesive polymers III. An in vivo transit and bioavailability study of drug loaded alginate and poly (fumaric-co-sebacic anhydride) microspheres","volume":"48","author":"Chickering","year":"1997","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2007.03.039_bib42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1023\/A:1015841531372","article-title":"Production of 5\u201315\u03bcm diameter alginate-polylysine microcapsules by an air-atomization technique","volume":"8","author":"Kwok Kk","year":"1991","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.vaccine.2007.03.039_bib43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/02652049709006815","article-title":"Production of BCG alginate-PLL microcapsules by emulsification\/internal gelation","volume":"14","author":"Esquisabel","year":"1997","journal-title":"J Microencapsul"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07003829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07003829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T12:18:26Z","timestamp":1683807506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07003829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":43,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0264410X07003829"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.03.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}